home / stock / adyx / adyx short
Short Information | Adynxx Inc (NYSE:ADYX)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 42,060 |
Total Actual Volume | 278,895 |
Short Trends | |
---|---|
Cover Days | 18 |
Short Days | 0 |
No Change Days | 2 |
Averages | |
---|---|
Average Short Volume | 2,103 |
Average Short Percentage | 18.43% |
Is there a ADYX Short Squeeze or Breakout about to happen?
See the ADYX Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
06-12-2019 | $5.88 | $3.61 | $5.88 | $3.53 | 113,912 | 9,789 | 8.59% |
06-11-2019 | $5.53 | $5.94 | $6.07 | $5.31 | 14,456 | 2,587 | 17.9% |
06-10-2019 | $4.91 | $5.43 | $5.43 | $4.91 | 9,635 | 1,936 | 20.09% |
06-07-2019 | $4.92 | $4.86 | $4.92 | $4.8549 | 3,089 | 726 | 23.5% |
06-06-2019 | $4.82 | $4.82 | $5.00 | $4.36 | 7,745 | 2,200 | 28.41% |
06-05-2019 | $5.07 | $4.64 | $5.12 | $4.64 | 12,222 | 1,033 | 8.45% |
06-04-2019 | $4.76 | $5.25 | $5.27 | $4.76 | 3,317 | 945 | 28.49% |
06-03-2019 | $5.54 | $5.321 | $5.88 | $4.7501 | 47,491 | 10,671 | 22.47% |
05-31-2019 | $5.94 | $6.20 | $6.25 | $4.75 | 5,688 | 537 | 9.44% |
05-30-2019 | $6.23 | $6.13 | $6.50 | $5.91 | 13,609 | 1,719 | 12.63% |
05-29-2019 | $6.36 | $6.35 | $6.41 | $6.2201 | 2,627 | 368 | 14.01% |
05-28-2019 | $6.0221 | $6.4696 | $6.548 | $6.00 | 2,215 | 252 | 11.38% |
05-24-2019 | $6.17 | $6.6074 | $6.7166 | $6.17 | 6,363 | 2,289 | 35.97% |
05-22-2019 | $6.47 | $6.51 | $6.7574 | $6.2391 | 7,554 | 601 | 7.96% |
05-21-2019 | $6.52 | $6.1908 | $6.6009 | $6.10 | 8,746 | 2,928 | 33.48% |
05-20-2019 | $6.9306 | $6.00 | $6.9306 | $6.00 | 5,687 | 900 | 15.83% |
05-17-2019 | $7.03 | $6.88 | $7.03 | $6.8712 | 2,763 | 1,250 | 45.24% |
05-16-2019 | $7.32 | $7.03 | $7.64 | $7.03 | 2,824 | 100 | 3.54% |
05-15-2019 | $7.02 | $7.3926 | $7.7003 | $7.02 | 6,259 | 1,154 | 18.44% |
05-14-2019 | $6.86 | $7.33 | $7.40 | $6.75 | 2,693 | 75 | 2.78% |
News, Short Squeeze, Breakout and More Instantly...
SAN FRANCISCO, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Adynxx, Inc. (OTCQB: ADYX), a clinical-stage biopharmaceutical company focused on the development of transcription factor decoy technology and first-in-class therapeutics for the treatment of pain and inflammatory diseases, today announced fi...
SAN FRANCISCO, Oct. 02, 2019 (GLOBE NEWSWIRE) -- Adynxx, Inc. (OTCQB: ADYX), a clinical-stage biopharmaceutical company focused on the development of transcription factor decoy technology and first-in-class therapeutics for the treatment of pain and inflammatory diseases, today announced th...
SAN FRANCISCO, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Adynxx, Inc. (OTCQB: ADYX), a clinical-stage biopharmaceutical company focused on the development of transcription factor decoy technology and first-in-class therapeutics for the treatment of pain and inflammatory diseases, today announced fi...